Epidemiological Study on Mental Health of Migrant Population in the Retention Center of Geispolsheim.

Mental Health of Migrant Population Clinical Trial

Official title:

Epidemiological Study on Mental Health of Migrant Population in the Retention Center of Geispolsheim

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04329936
• Other study ID #: 7657
• Status: Not yet recruiting
• Start date: May 2020
• Est. completion date: May 2021

Study information

• Verified date: March 2020
• Source: University Hospital, Strasbourg, France
• Contact: RADJI Djamel
• Phone: +33 3 88 11 65 42
• Email: djamel.radji[@]chru-strasbourg.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

In 2019, the lack of studies about mental health of the detained population at retention centers in France is pointed out by the report of Controller-General for Places of Deprivation of Liberty. The aim of this study is to contribute to this relatively untouched field by describing which psychiatric pathologies are encountered in this population who went through migration and retention. Having a clearer picture of the situation can help to provide a more adapted psychiatric care in retention centers.

The results are expected to show a higher rate of psychiatric disease than in the general population including addiction to substance, anxiety disorder and post-traumatic stress disorder (PTSD).

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 30
• Est. completion date: May 2021
• Est. primary completion date: May 2020
• Accepts healthy volunteers: No
• Gender: Male
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Any male person in the first week of detention at CRA Geispolsheim who gave their non-opposition to participation in the study.

• Information and consent protocol signed

Exclusion Criteria:

• Refuse to participate to the study

Related Conditions & MeSH terms

• Mental Health of Migrant Population

Intervention

Behavioral:
• Retention center Geispolsheim population
All recently held individuals in the retention center can be included in the study after signing the information and consent protocol.

Locations

Country	Name	City	State
France	Les Hôpitaux Universitaires de Strasbourg	Strasbourg

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Mini International Neuropsychiatric Interview validated and translated in the language used by the interviewed person.	The interview is led by the investigator in the presence of a translator if necessary.	1 hour